ArticleDiabetology & metabolic syndrome2026

Association of dual SGLT-2 inhibitor and GLP-1 receptor agonist therapy with colon cancer risk in post-polypectomy patients with diabetes: a target trial emulation.

Chih-Hsuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.